Public Health Emergency - Leading a Nation Prepared
The availability of licensed anthrax antitoxins further expands the options available to treat anthrax infections in an emergency, especially when used appropriately in combination with other anthrax medical countermeasures.
The following BARDA-supported anthrax antitoxins have all been approved by FDA and have been procured for use in the event of an emergency:
BARDA will continue to work with its interagency partners, particularly those in the PHEMCE, as they support development of next generation or alternative therapies to treat individuals symptomatic with anthrax disease.
Home | Contact Us | Accessibility | Privacy Policies | Disclaimer | HHS Viewers & Players | HHS Plain Language | Vulnerability Disclosure Policy
Assistant Secretary for Preparedness and Response (ASPR), 200 Independence Ave., SW, Washington, DC 20201
U.S. Department of Health and Human Services | USA.gov |
HealthCare.gov in Other Languages